— Know what they know.
Not Investment Advice

CHEK NASDAQ

Check-Cap Ltd.
1W: -1.7% 1M: +13.4% 3M: -21.9% 1Y: +189.4% 3Y: -41.2% 5Y: -73.8%
$1.86
Last traded 2025-12-18 — delisted
NASDAQ · Healthcare · Medical - Diagnostics & Research · $10.9M mcap · 6M float · 54.65% daily turnover · Short 26% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
-$161K +24.1% ▲
Operating Income
-$26M -34.5% ▼
Net Income
-$25M -43.2% ▼
EPS (Diluted)
$-4.30 -43.3% ▼
EBITDA
-$9M +47.3% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$148K$205K$405K$212K$161K
Gross Profit-$148K-$205K-$405K-$212K-$161K
Gross Margin—————
R&D Expenses$10M$12M$14M$8M$0
SG&A Expenses$4M$5M$6M$10M$9M
Operating Expenses$14M$17M$20M$18M$26M
Operating Income-$14M-$17M-$20M-$19M-$26M
Operating Margin—————
Interest Expense$12K$13K$12K$13K$9K
Income Before Tax-$14M-$17M-$19M-$18M-$25M
Tax Expense$0$0$0$0$0
Net Income-$14M-$17M-$19M-$18M-$25M
Net Margin—————
EPS (Diluted)$-9.12$-4.13$-3.37$-3.00$-4.30
EBITDA-$14M-$17M-$19M-$18M-$9M
Shares Outstanding2M4M6M6M6M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms